Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (U01 Clinical Trial Optional)
ID: 344665Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/344665

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-037.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity titled "Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities" (PAR-23-037). This initiative aims to support multisite clinical trials and observational studies that utilize the NICHD Clinical Research Networks, focusing on enhancing the rigor of research protocols, promoting diverse population involvement, and facilitating data sharing and access to biospecimens. The opportunity is particularly significant for advancing research in maternal and child health and disabilities, emphasizing collaboration between investigators and existing NICHD infrastructure. Applications are accepted until May 8, 2026, and interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-037.html
    The Department of Health and Human Services, through the National Institutes of Health, has issued a funding opportunity announcement (FOA) entitled "Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities" (PAR-23-037). The primary aim is to support multisite clinical trials and observational studies utilizing the NICHD Clinical Research Networks to advance research in maternal and child health and disabilities. Key objectives include enhancing the rigor of protocols, promoting diverse population involvement, and ensuring data sharing and access to biospecimens. Applications must undergo a pre-application process starting with a Letter of Inquiry, followed by a detailed Concept Proposal, ultimately leading to a multi-Principal Investigator grant application. The FOA emphasizes diverse participation in research, adherence to NICHD guiding principles, and collaboration between investigators and existing NICHD infrastructure. Submissions are open until May 8, 2026, with specific deadlines for the application process. The announcement encourages the integration of underrepresented populations and establishes key milestones for project progression. The FOA underscores the NICHD's commitment to advancing effective and equitable research through cooperative agreements, ensuring substantial Federal involvement in selected projects.
    Similar Opportunities
    Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities" through a cooperative agreement mechanism. This initiative aims to utilize NICHD clinical research network infrastructure to support multisite, investigator-initiated clinical trials and observational studies, focusing on improving health outcomes for vulnerable populations. The funding opportunity emphasizes the importance of diverse participant enrollment and collaboration, requiring applicants to develop a Plan for Enhancing Diverse Perspectives and a Data Management and Sharing Plan. The maximum funding amount is $6,250,000, with a project period of up to seven years, and applications are due by November 15, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PAR-25-311.html.
    Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)" aimed at advancing precision medicine for pregnant individuals, lactating persons, and children. This grant seeks to support innovative research that develops novel tools and technologies, enhances understanding of drug mechanisms, and improves therapeutic options for these populations, particularly those with disabilities. The initiative is part of the R21 Exploratory/Developmental Research Grants program, with a funding cap of $275,000 over a potential two-year period, and requires a Data Management and Sharing Plan as part of the application process. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with the application deadline set for May 7, 2026.
    Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)" aimed at advancing research in drug safety and effectiveness for pregnant individuals, lactating persons, and children. This initiative seeks to support innovative projects that develop novel methodologies, enhance understanding of drug mechanisms, and promote precision medicine to address significant unmet medical needs in maternal and pediatric health. Eligible applicants include a wide range of institutions, such as historically black colleges and universities, tribal colleges, and various nonprofit organizations, with funding available up to $275,000 over a two-year period. Interested parties should note that applications are accepted until December 16, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)" aimed at advancing precision medicine for pregnant individuals, lactating individuals, and children. This initiative seeks to support translational and clinical research that develops novel therapeutic tools, enhances understanding of drug mechanisms, and improves medication safety and efficacy for these vulnerable populations. The program emphasizes interdisciplinary collaboration to address unmet therapeutic needs and promote better health outcomes in maternal and pediatric medicine. Applications will be accepted starting January 5, 2025, with a closing date of May 7, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-110.html.
    NICHD Small Research Grant Program (R03 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NICHD Small Research Grant Program (R03 Clinical Trial Required) to support clinical trials aligned with the mission of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This program aims to fund small-scale research projects, including pilot studies and methodological development, with a maximum budget of $50,000 per year for up to two years. The funding is crucial for advancing knowledge in human development fields, particularly in childhood development and rehabilitation medicine. Interested applicants must adhere to specific guidelines and register with Grants.gov and eRA Commons, with the application window opening on January 16, 2025, and closing on January 8, 2028. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality" (NOFO PAR-24-059). This initiative aims to support multidisciplinary research focused on addressing the high rates of maternal morbidity and mortality in the United States, particularly among racial and ethnic minorities, socioeconomically disadvantaged groups, and underserved rural populations. The program encourages innovative intervention studies that evaluate healthcare factors affecting maternal health, with the goal of reducing disparities and improving outcomes across the continuum of care from prenatal to postpartum. Eligible applicants include a range of organizations, and awards can last up to five years, with budgets tailored to project needs. Interested parties can find more information and apply by visiting the NIH grants website, with the application deadline set for January 7, 2027.
    Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)" aimed at advancing precision medicine for pregnant individuals, lactating persons, and children. This grant seeks to support translational and clinical research that develops novel tools and methodologies to enhance the understanding of drug action mechanisms and improve the safety and effectiveness of therapeutics for these populations. The initiative is crucial for addressing critical gaps in healthcare for vulnerable groups, with a focus on discovering safer medications and utilizing innovative approaches such as machine learning for precision dosing. Interested applicants can find more information and submit proposals by May 7, 2026, and should direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Maternal and Pediatric Precision in Therapeutics (MPRINT) Knowledge and Research Coordination Center
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for the establishment of the Maternal and Pediatric Precision in Therapeutics (MPRINT) Knowledge and Research Coordination Center through a cooperative agreement. This initiative aims to enhance drug development and regulatory science for maternal and pediatric therapeutics by creating a pharmacology knowledgebase, utilizing real-world clinical data, and fostering innovative clinical trials, while also training the future workforce in this critical area. The total estimated funding for this program is $3,625,000, with one award anticipated, and interested parties can reach out to Lesly-Anne Samedy-Bates at lesly-anne.samedy-bates@nih.gov or by phone at 301-219-7492 for further information. The estimated synopsis post date is November 21, 2025, with a closing date for applications expected by March 2, 2026, and project commencement anticipated on December 1, 2026.
    Community-Partnered Nursing Research Centers (P20 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Community-Partnered Nursing Research Centers (P20 Clinical Trial Optional) grant, aimed at establishing innovative nursing-led research centers that focus on community-partnered research to tackle persistent health challenges. Applicants are required to propose strategies that enhance research infrastructure within Schools or Colleges of Nursing, develop nurse-led interdisciplinary teams, and engage the community meaningfully throughout all research activities, including the execution of at least one pilot project that generates preliminary data for future NIH submissions. This initiative is critical for fostering sustainable research infrastructure and improving health outcomes in diverse communities. The grant offers a maximum funding amount of $500,000 per year for a project period of up to five years, with applications due by May 7, 2028. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-439.html.
    Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Health and Health Care Disparities Among Persons Living with Disabilities" (R01 - Clinical Trials Optional) aimed at supporting innovative research that addresses the health challenges faced by individuals with disabilities, particularly in relation to race, ethnicity, and socio-economic status. The initiative seeks to investigate the systemic factors that adversely affect the health and well-being of this population, with a focus on understanding barriers to healthcare access and developing effective interventions to mitigate disparities. This funding opportunity is crucial for enhancing healthcare outcomes for marginalized groups living with disabilities through collaborative, community-engaged research. Interested applicants can apply for grants with an award ceiling of $500,000, and the application process opened on January 5, 2024, with a submission deadline of November 5, 2026. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-309.html.